Halozyme Therapeutics reported $93.05M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -43709000 23.06M
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amarin AMRN:US 8.77M 10.1M
Amgen AMGN:US $ 2333M 204M
Aptinyx Inc APTX:US $ -19866000 5.58M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Baxter International BAX:US $ 476M 50M
Cara Therapeutics CARA:US $ -30876000 7.32M
Cytokinetics CYTK:US $ -54797000 14.19M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Halozyme Therapeutics HALO:US $ 93.05M 42.31M
Immunogen IMGN:US $ -27369000 1.55M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
Intra Cellular Therapies ITCI:US $ -69141060 15.92M
JAZZ PHA JAZZ:US -69590000 231.71M
Mannkind MNKD:US $ -9031000 998K
Minerva Neurosciences NERV:US $ -8963290 1.46M
Nektar Therapeutics NKTR:US $ -110205000 813K
Peregrine Pharmaceuticals PPHM:US $ 6.93M 3.84M
Pfizer PFE:US $ 6662M 905M
Rigel Pharmaceuticals RIGL:US $ -13048000 54.8M
United Therapeutics UTHR:US $ 222.2M 263.9M
Vanda Pharmaceuticals VNDA:US $ 12.37M 2.03M